Charting the Course for Monoclonal Antibodies in Immunodiagnosis and Immunotherapy

Abstract

Get full access to this article

View all access options for this article.

References

Kohler

, Nara

. A novel hypothesis for original antigenic sin in the severe disease of SARS-CoV-2 Infection. Monoclon Antib Immunodiagn Immunother, 2020; 39(4):107–111.

Kieber-Emmons

, Brown

, Nara

, et al. Expert panel discussion on antigenic sin. Monoclon Antib Immunodiagn Immunother, 2021; 40(5):203–209.

Kieber-Emmons

. The gift that keeps on giving. Monoclon Antib Immunodiagn Immunother, 2024; 43(2):33–34.

The Antibody Society. Therapeutic monoclonal antibodies approved or in review in the EU or US. (date accessed). Available from: www.antibodysociety.org/resources/approved-antibodies

The Antibody Society. Antibody therapeutics in late-stage clinical studies. (date accessed); Available from: www.antibodysociety.org/antibodies-in-late-stage-clinical-studies/

Moroz

. Thinking outside the box to obtain the best antibodies!. Monoclon Antib Immunodiagn Immunother, 2021; 40(5):201–202.

Soeta

, Yamaguchi

, Iuchi

, et al. Generation of rat monoclonal antibody for human IQGAP1 by immunization of three-dimensional-cultured cancer cells. Monoclon Antib Immunodiagn Immunother, 2021; 40(3):118–123.

Bennett

, Watson

, Ragotte

, et al. Atomically accurate de novo design of single-domain antibodies. bioRxiv, 2024 page:2024.03.14.585103.

Abramson

, Adler

, Dunger

, et al. Accurate structure prediction of biomolecular interactions with AlphaFold 3. Nature [Internet], 2024; doi: 10.1038/s41586-024-07487-w